Cardiopulmonary exercise testing in chronic obstructive pulmonary disease.

Area of Science:

• Pulmonary Medicine
• Exercise Physiology

Background:

• Chronic obstructive pulmonary disease (COPD) significantly impacts quality of life due to exercise intolerance.
• Current COPD treatments struggle to fully address exercise limitations.
• Cardiopulmonary exercise testing (CPET) offers a comprehensive assessment of physiological responses to exercise.

Purpose of the Study:

• To evaluate the clinical utility of CPET in managing COPD patients.
• To assess CPET's role in determining exercise tolerance, disease progression, and treatment efficacy.
• To investigate the prognostic value of CPET in COPD.

Main Methods:

• A systematic literature review of studies published between 2020 and 2024.
• Focus on CPET's prognostic value, correlation with COPD severity, and impact on therapeutic strategies.
• Study quality assessed using PRISMA guidelines.

Main Results:

• CPET parameters like peak oxygen uptake (V̇O2 peak) and ventilatory efficiency (V̇E/V̇CO2 slope) correlate with COPD severity and prognosis.
• A V̇O2 peak below 15 mL kg-1 min-1 indicates increased mortality risk.
• CPET-derived thresholds are crucial for COPD diagnosis, management, and optimizing rehabilitation.

Conclusions:

• CPET is vital for understanding COPD exercise intolerance pathophysiology.
• CPET aids in personalized treatment strategies and risk stratification for COPD patients.
• Integration of CPET into COPD management guidelines is recommended.